Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Anisha Dua

Vasculitis · NU

View

Dr. Karen Salomon-Escoto

General Rheumatology · UMMHC

View

Dr. Jeffrey Sparks

General Rheumatology · PHS

View

Dr. Sara Tedeschi

Crystal-Related Diseases · BWH

View

Dr. Amanda Nelson

General Rheumatology · UNC

View

Dr. Alfred Kim

Lupus · WUSTL

View

Dr. Saira Sheikh

Lupus · UNC

View

Dr. Eleni Tiniakou

Myositis · UTHealth

View

Dr. Nilasha Ghosh

General Rheumatology · HSS

View

Dr. Simon Helfgott

General Rheumatology · BWH

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    MPDr. Mike Putman
    Leading Voice

    Dr. Mike Putman

    Rheumatology · Vasculitis
    Froedtert Hospital
    michaelputman

    Research

    Increased apathy level in systemic lupus erythematosus

    2026

    Via Clinical Rheumatology

    Research

    Positive and negative controls in rheumatology research

    2025

    Via Rheumatology (Oxford, England)

    Research

    Incidence of Pneumocystis Pneumonia and Prophylaxis-Associated Adverse Events Among Patients With Systemic Lupus Erythematosus

    2025

    Via The Journal of Rheumatology

    Research

    2023 American College of Rheumatology/American College of Chest Physicians guideline for the screening and monitoring of interstitial lung disease in people with systemic autoimmune rheumatic diseases: comment on the article by Johnson et al

    2025

    Via Arthritis & Rheumatology

    Research

    The National Academies' 2024 Diagnostic Criteria for Long COVID: Concerns That Could Affect the Rheumatology Community

    2025

    Via Arthritis & Rheumatology

    Research

    Comparative effectiveness of disease-modifying antirheumatic drugs for patients with cardiac sarcoidosis

    2025

    Via Rheumatology (Oxford, England)

    Research

    Incidence of aortic aneurysm, dissection, or rupture among patients with polymyalgia rheumatica and giant cell arteritis

    2025

    Via Seminars in Arthritis and Rheumatism

    Research

    The fragility of randomized controlled trials in large vessel vasculitis

    2025

    Via Autoimmunity Reviews

    Research

    Utilization of interleukin-1 antagonists for management of recurrent pericarditis

    2025

    Via The American Journal of the Medical Sciences

    Research

    Fragility of randomised controlled trials for systemic lupus erythematosus and lupus nephritis therapies

    2024

    Via Lupus Science & Medicine

    Research

    Incidence of Pneumocystis Jiroveci Pneumonia in Patients With ANCA-Associated Vasculitis Initiating Therapy With Rituximab or Cyclophosphamide

    2024

    Via Arthritis Care & Research

    Research

    Impact of Glucocorticoid Dose on Complete Response, Serious Infections, and Mortality During the Initial Therapy of Lupus Nephritis: A Systematic Review and Meta-Analysis of the Control Arms of Randomized Controlled Trials

    2024

    Via Arthritis & Rheumatology

    Research

    The State of Patient-Reported Outcome Measures in Rheumatology

    2024

    Via The Journal of Rheumatology

    Research

    Recommendations for early referral of individuals with suspected polymyalgia rheumatica: an initiative from the international giant cell arteritis and polymyalgia rheumatica study group

    2024

    Via Annals of the Rheumatic Diseases

    Research

    The emerging risk of overdiagnosis in rheumatoid arthritis and polymyalgia rheumatica

    2024

    Via The Lancet. Rheumatology